These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 30128626)

  • 1. Uncoupling Warburg effect and stemness in CD133
    Koka P; Mundre RS; Rangarajan R; Chandramohan Y; Subramanian RK; Dhanasekaran A
    Mol Biol Rep; 2018 Dec; 45(6):1653-1662. PubMed ID: 30128626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
    Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
    Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
    Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
    Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
    Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia promotes stem-like properties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction.
    Wu CP; Du HD; Gong HL; Li DW; Tao L; Tian J; Zhou L
    Int J Oncol; 2014 May; 44(5):1652-60. PubMed ID: 24573690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of CD133
    Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
    BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
    Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
    Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential mechanisms of CD133 in cancer stem cells.
    Jang JW; Song Y; Kim SH; Kim J; Seo HR
    Life Sci; 2017 Sep; 184():25-29. PubMed ID: 28697984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133(+) CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma.
    He A; Yang X; Huang Y; Feng T; Wang Y; Sun Y; Shen Z; Yao Y
    J Cell Biochem; 2015 Aug; 116(8):1719-29. PubMed ID: 25736420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete radiofrequency ablation promotes the development of CD133
    Yuan CW; Wang ZC; Liu K; Liu DJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):416-422. PubMed ID: 30262419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of DNA-PKcs suppresses P-gp expression via inhibition of the Akt/NF-κB pathway in CD133-positive osteosarcoma MG-63 cells.
    Li K; Li X; Tian J; Wang H; Pan J; Li J
    Oncol Rep; 2016 Oct; 36(4):1973-80. PubMed ID: 27499034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenite inhibits the function of CD133
    Tang H; Jin Y; Jin S; Tan Z; Peng Z; Kuang Y
    Tumour Biol; 2016 Oct; 37(10):14103-14115. PubMed ID: 27517564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of cancer stem cell-based tumoroids as an osteosarcoma model.
    Ozturk S; Gorgun C; Gokalp S; Vatansever S; Sendemir A
    Biotechnol Bioeng; 2020 Aug; 117(8):2527-2539. PubMed ID: 32391924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.
    Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; Fazioli F; Pirozzi G; Papaccio G
    FASEB J; 2011 Jun; 25(6):2022-30. PubMed ID: 21385990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
    Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
    Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells.
    Chang Y; Zhao Y; Zhan H; Wei X; Liu T; Zheng B
    Tumour Biol; 2014 Feb; 35(2):1075-82. PubMed ID: 24006225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.